+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Shrimp Disease Diagnostics Market by Kit, Disease, End User - Global Forecast 2025-2030- Product Image
Shrimp Disease Diagnostics Market by Kit, Disease, End User - Global Forecast 2025-2030- Product Image
Sale

Shrimp Disease Diagnostics Market by Kit, Disease, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 183 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5017278
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Shrimp Disease Diagnostics Market grew from USD 443.18 million in 2023 to USD 478.10 million in 2024. It is expected to continue growing at a CAGR of 7.92%, reaching USD 755.83 million by 2030.

The scope of shrimp disease diagnostics encompasses tools and technologies used to identify and manage diseases affecting shrimp aquaculture, such as viral, bacterial, and parasitic infections. Given the increasing global demand for shrimp, ensuring the health of shrimp stock is imperative. Disease diagnostics is crucial as it enables early detection of pathogens, minimizing outbreaks and ensuring aquaculture sustainability. Applications primarily include laboratory testing and on-site rapid diagnostic kits used by shrimp farms, hatcheries, and veterinary services.

Market insights reveal that the growth of shrimp disease diagnostics is influenced by the rising incidences of shrimp diseases and the increasing investment in aquaculture. Technological advancements in molecular diagnostics, such as PCR and biosensors, are propelling the industry forward. Opportunities exist in developing more affordable and accessible rapid diagnostic kits, especially for small-scale aquaculture operators in developing countries, to ensure widespread adoption of these technologies. Expansion into new markets in Asia and Latin America, where aquaculture drives economies, also provides substantial growth potential.

Challenges restrain market growth, such as the high costs associated with advanced diagnostic technologies and varying regulations across countries, leading to compliance complexities. Another limitation is the lack of awareness and technical expertise in some regions, hindering the adoption of advanced diagnostics.

Innovation can be directed towards non-invasive diagnostic methods, AI-based predictive analytics for disease outbreaks, and the integration of IoT in aquaculture for real-time health monitoring. Emphasizing R&D in these areas may yield significant business growth. The market is notably dynamic, with a trend towards consolidation, as mergers and acquisition activities increase among diagnostic companies seeking to expand their capabilities and market presence. Navigating these trends with a focus on collaboration and technology-driven solutions is crucial for maintaining a competitive edge in the shrimp disease diagnostics field.

Understanding Market Dynamics in the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing shrimp production and export activities worldwide
    • Public-private awareness initiatives and welfare projects to tackle shrimp diseases
    • Regulations for quality shrimp farming and need for efficient disease detection tools
  • Market Restraints
    • Complex testing procedures and need for trained personnel
  • Market Opportunities
    • Advancements in shrimp diagnostics technologies and rapid testing methods
    • New investments in expansion of shrimp farming activities
  • Market Challenges
    • Limitations associated with false positives and inaccuracy of shrimp disease diagnostics

Exploring Porter’s Five Forces for the Shrimp Disease Diagnostics Market

Porter’s Five Forces framework further strengthens the insights of the Shrimp Disease Diagnostics Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Shrimp Disease Diagnostics Market

External macro-environmental factors deeply influence the performance of the Shrimp Disease Diagnostics Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Shrimp Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include 3 Little Fish Sdn Bhd, Amazing Biotech, Aquaintech Inc., Arachem (M) Sdn Bhd, Bioneer Corporation, Blue Aqua International Pte. Ltd., CD Genomics, China Guangzhou BioKey Healthy Technology Co. Ltd, DSM Austria GmbH, Forte Biotech, GeneReach Biotechnology Corp., GeneReach Biotechnology Corporation, Genics Pty. Ltd., Illumina, Inc., Innocreate Bioscience Co., Ltd., Lab-Ind Resource Sdn. Bhd., Laboratory Corporation of America Holdings, Mahesh Aqua Holdings (Pvt) Ltd., Mylab Discovery Solutions Pvt. Ltd., PT Riset Nusantara Genetika (Nusantics), Randox Laboratories Ltd., Reagen LLC, Ring Biotechnology Co Ltd., Speedy Assay Sdn. Bhd., SUREBIO, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Shrimp Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Kit
    • Assay Based Kit
    • Rapid Testing Kit
  • Disease
    • Early Mortality Syndrome
    • Taura Syndrome Virus
    • White Spot Syndrome Virus
    • Yellow Head or Gill Associated Virus
  • End User
    • Aquaculture & Marine Laboratories
    • Education & Research Institutes
    • Fisheries
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing shrimp production and export activities worldwide
5.1.1.2. Public-private awareness initiatives and welfare projects to tackle shrimp diseases
5.1.1.3. Regulations for quality shrimp farming and need for efficient disease detection tools
5.1.2. Restraints
5.1.2.1. Complex testing procedures and need for trained personnel
5.1.3. Opportunities
5.1.3.1. Advancements in shrimp diagnostics technologies and rapid testing methods
5.1.3.2. New investments in expansion of shrimp farming activities
5.1.4. Challenges
5.1.4.1. Limitations associated with false positives and inaccuracy of shrimp disease diagnostics
5.2. Market Segmentation Analysis
5.2.1. Kit: Growing adoption of rapid testing kits for quick and easy detection of pathogens
5.2.2. Disease: Highly contagious nature of white spot syndrome virus (WSSV) necessitating quality PCR and histological tests
5.2.3. End User: Rising incidences of shrimp disease outbreaks in fisheries necessitating deployment of shrimp disease diagnostics strategies
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Shrimp Disease Diagnostics Market, by Kit
6.1. Introduction
6.2. Assay Based Kit
6.3. Rapid Testing Kit
7. Shrimp Disease Diagnostics Market, by Disease
7.1. Introduction
7.2. Early Mortality Syndrome
7.3. Taura Syndrome Virus
7.4. White Spot Syndrome Virus
7.5. Yellow Head or Gill Associated Virus
8. Shrimp Disease Diagnostics Market, by End User
8.1. Introduction
8.2. Aquaculture & Marine Laboratories
8.3. Education & Research Institutes
8.4. Fisheries
9. Americas Shrimp Disease Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Shrimp Disease Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Shrimp Disease Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. US Project to Develop Low-Cost White Spot Test for Shrimp Farmers
12.3.2. ViAqua Therapeutics Secures Funding for RNA-based Aquaculture Disease Management
12.3.3. Aquatreck Signs Research Agreement to Develop Diagnostic Services for Fish Farms
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. SHRIMP DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SHRIMP DISEASE DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAY BASED KIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY ASSAY BASED KIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RAPID TESTING KIT, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY RAPID TESTING KIT, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EARLY MORTALITY SYNDROME, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EARLY MORTALITY SYNDROME, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TAURA SYNDROME VIRUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY TAURA SYNDROME VIRUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WHITE SPOT SYNDROME VIRUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY WHITE SPOT SYNDROME VIRUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY YELLOW HEAD OR GILL ASSOCIATED VIRUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY YELLOW HEAD OR GILL ASSOCIATED VIRUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE & MARINE LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY AQUACULTURE & MARINE LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FISHERIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY FISHERIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 51. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 52. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 53. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 54. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 55. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 56. CANADA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 57. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 58. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 59. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 60. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 61. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 62. MEXICO SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 85. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 86. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 87. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 88. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 89. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 90. CHINA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 91. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 92. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 93. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 94. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 95. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 96. INDIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 103. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 104. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 105. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 106. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 107. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 108. JAPAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 139. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 140. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 141. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 142. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 143. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 144. THAILAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 160. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 161. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 162. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 163. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 164. DENMARK SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 165. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 166. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 167. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 168. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 169. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 170. EGYPT SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 171. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 172. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 173. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 174. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 175. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 176. FINLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 177. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 178. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 179. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 180. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 181. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 182. FRANCE SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 183. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 184. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 185. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 186. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 187. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 188. GERMANY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 195. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 196. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 197. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 198. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 199. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 200. ITALY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 213. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 214. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 215. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 216. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 217. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 218. NORWAY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 219. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 220. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 221. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 222. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 223. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 224. POLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 225. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 226. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 227. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 228. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 229. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 230. QATAR SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 249. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 250. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 251. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 252. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 253. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 254. SPAIN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 267. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 268. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 269. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 270. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 271. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 272. TURKEY SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY KIT, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM SHRIMP DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
TABLE 285. SHRIMP DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. SHRIMP DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Shrimp Disease Diagnostics market, which are profiled in this report, include:
  • 3 Little Fish Sdn Bhd
  • Amazing Biotech
  • Aquaintech Inc.
  • Arachem (M) Sdn Bhd
  • Bioneer Corporation
  • Blue Aqua International Pte. Ltd.
  • CD Genomics
  • China Guangzhou BioKey Healthy Technology Co. Ltd
  • DSM Austria GmbH
  • Forte Biotech
  • GeneReach Biotechnology Corp.
  • GeneReach Biotechnology Corporation
  • Genics Pty. Ltd.
  • Illumina, Inc.
  • Innocreate Bioscience Co., Ltd.
  • Lab-Ind Resource Sdn. Bhd.
  • Laboratory Corporation of America Holdings
  • Mahesh Aqua Holdings (Pvt) Ltd.
  • Mylab Discovery Solutions Pvt. Ltd.
  • PT Riset Nusantara Genetika (Nusantics)
  • Randox Laboratories Ltd.
  • Reagen LLC
  • Ring Biotechnology Co Ltd.
  • Speedy Assay Sdn. Bhd.
  • SUREBIO
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 478.1 Million
Forecasted Market Value ( USD ) by 2030 $ 755.83 Million
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Invertebrate Medicine. Edition No. 3 - Product Image

Invertebrate Medicine. Edition No. 3

  • Book
  • 752 Pages
Veterinary Diagnostic Market by Product, Animal Type, Testing Category, Disease Type, End-Use - Global Forecast 2025-2030 - Product Image

Veterinary Diagnostic Market by Product, Animal Type, Testing Category, Disease Type, End-Use - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Global Forecast 2025-2030 - Product Image

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Indication, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Veterinary Molecular Diagnostics Market Size, Share & Trends Analysis Report By Product, By Animal Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
U.S. Veterinary Point of Care Diagnostics Market Size, Share & Trends Analysis Report by Product, Animal Type, Sample Type, Indication, Testing Category, End-Use, Country with Growth Forecasts, 2025-2030 - Product Image

U.S. Veterinary Point of Care Diagnostics Market Size, Share & Trends Analysis Report by Product, Animal Type, Sample Type, Indication, Testing Category, End-Use, Country with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • United States
From

About the Shrimp Disease Diagnostics Market

The Shrimp Disease Diagnostics market is a segment of the Animal Healthcare/Veterinary industry. It focuses on the diagnosis and treatment of diseases that affect shrimp, a type of crustacean. Diagnostic tests are used to identify the presence of disease-causing agents, such as bacteria, viruses, and parasites. These tests can be used to detect the presence of disease in shrimp, as well as to monitor the effectiveness of treatments. Diagnostic tests are also used to monitor the health of shrimp populations, as well as to detect the presence of disease-causing agents in the environment. The Shrimp Disease Diagnostics market is driven by the increasing demand for shrimp, as well as the need to ensure the health and safety of shrimp populations. The market is also driven by advances in technology, such as the development of new diagnostic tests and the use of molecular techniques. Companies in the Shrimp Disease Diagnostics market include Bio-Rad Laboratories, Thermo Fisher Scientific, QIAGEN, and Genetwister Technologies. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.